Binje Vick
- Hematology top 5%
- Acute Myeloid Leukemia Research 14
- Oncology top 5%
- CAR-T cell therapy research 4
- Immunology top 10%
- Immune Cell Function and Interaction 4
- Hepatology top 10%
-
- RNA Interference and Gene Delivery 5
- Cell death mechanisms and regulation 5
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 3
- Co-authors
- Irmela JeremiasToni UrbanikPeter R. GalleHenning Schulze‐BergkamenMarcus SchuchmannAchim WeberKarsten SpiekermannMarion Subklewe
- Cited by
- HematologyOncologyImmunology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Binje Vick
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Hematology 248
- Oncology 471
- Immunology 314
- Hepatology 67
- Molecular Biology 540
Countries citing papers authored by Binje Vick
This map shows the geographic impact of Binje Vick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binje Vick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binje Vick more than expected).
Fields of papers citing papers by Binje Vick
This network shows the impact of papers produced by Binje Vick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binje Vick. The network helps show where Binje Vick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Binje Vick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 39 | |
| 5 | 2021 | 28 | |
| 6 | 2021 | 26 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 33 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 13 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 79 | |
| 14 | 2017 | 12 | |
| 15 | 2015 | 48 | |
| 16 | 2009 | 95 | |
| 17 | 2009 | 31 | |
| 18 | 2008 | 125 | |
| 19 | 2008 | 37 | |
| 20 | 2008 | 1 |
About Binje Vick
Binje Vick is a scholar working on Hematology, Physiology and Immunology, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), RNA Interference and Gene Delivery (5 papers), Cell death mechanisms and regulation (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (248 citations), Oncology (471 citations) and Immunology (314 citations). Binje Vick has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Irmela Jeremias, Toni Urbanik, Peter R. Galle, Henning Schulze‐Bergkamen, Marcus Schuchmann, Achim Weber, Karsten Spiekermann, Marion Subklewe, Andreas Teufel and Klaus H. Metzeler. Their work appears in journals such as Blood, Leukemia, Oncotarget, World Journal of Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.